These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 24621150)
21. Factors associated with hearing loss in a normal-hearing guinea pig model of Hybrid cochlear implants. Tanaka C; Nguyen-Huynh A; Loera K; Stark G; Reiss L Hear Res; 2014 Oct; 316():82-93. PubMed ID: 25128626 [TBL] [Abstract][Full Text] [Related]
22. Sustained-Release Triamcinolone Acetonide Hydrogels Reduce Hearing Threshold Shifts in a Model for Cochlear Implantation with Hearing Preservation. Honeder C; Zhu C; Gausterer JC; Schöpper H; Ahmadi N; Saidov N; Nieratschker M; Gabor F; Arnoldner C Audiol Neurootol; 2019; 24(5):237-244. PubMed ID: 31574511 [TBL] [Abstract][Full Text] [Related]
23. Hearing Protection Outcomes of Analog Electrode Arrays Coated with Different Drug-Eluting Polymer Films Implanted into Guinea Pig Cochleae. Huang Y; Yu H; Liang M; Hou S; Chen J; Zhang F; Sun X; Jia H; Yang J Drug Des Devel Ther; 2021; 15():3443-3450. PubMed ID: 34413631 [TBL] [Abstract][Full Text] [Related]
24. Protective effect of systemic administration of erythropoietin on auditory brain stem response and compound action potential thresholds in an animal model of cochlear implantation. Quesnel S; Nguyen Y; Campo P; Hermine O; Ribeil JA; Elmaleh M; Grayeli AB; Ferrary E; Sterkers O; Couloigner V Ann Otol Rhinol Laryngol; 2011 Nov; 120(11):737-47. PubMed ID: 22224316 [TBL] [Abstract][Full Text] [Related]
26. A 3D Microscaffold Cochlear Electrode Array for Steroid Elution. Jang J; Kim JY; Kim YC; Kim S; Chou N; Lee S; Choung YH; Kim S; Brugger J; Choi H; Jang JH Adv Healthc Mater; 2019 Oct; 8(20):e1900379. PubMed ID: 31532887 [TBL] [Abstract][Full Text] [Related]
27. Effects of systemic administration of methylprednisolone on residual hearing in an animal model of cochlear implantation. Quesnel S; Nguyen Y; Elmaleh M; Grayeli AB; Ferrary E; Sterkers O; Couloigner V Acta Otolaryngol; 2011 Jun; 131(6):579-84. PubMed ID: 21190421 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of hearing loss from trauma and inflammation: otoprotective therapies from the laboratory to the clinic. van de Water TR; Dinh CT; Vivero R; Hoosien G; Eshraghi AA; Balkany TJ Acta Otolaryngol; 2010 Mar; 130(3):308-11. PubMed ID: 19579145 [TBL] [Abstract][Full Text] [Related]
29. D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma. Eshraghi AA; He J; Mou CH; Polak M; Zine A; Bonny C; Balkany TJ; Van De Water TR Otol Neurotol; 2006 Jun; 27(4):504-11. PubMed ID: 16791042 [TBL] [Abstract][Full Text] [Related]
30. Dexamethasone eluting electrodes for cochlear implantation: Effect on residual hearing. Douchement D; Terranti A; Lamblin J; Salleron J; Siepmann F; Siepmann J; Vincent C Cochlear Implants Int; 2015 Jul; 16(4):195-200. PubMed ID: 24593762 [TBL] [Abstract][Full Text] [Related]
31. Insertion site and sealing technique affect residual hearing and tissue formation after cochlear implantation. Burghard A; Lenarz T; Kral A; Paasche G Hear Res; 2014 Jun; 312():21-7. PubMed ID: 24566091 [TBL] [Abstract][Full Text] [Related]
32. Dexamethasone eluting cochlear implant: Histological study in animal model. Farhadi M; Jalessi M; Salehian P; Ghavi FF; Emamjomeh H; Mirzadeh H; Imani M; Jolly C Cochlear Implants Int; 2013 Jan; 14(1):45-50. PubMed ID: 22333428 [TBL] [Abstract][Full Text] [Related]
33. A soft-surgery approach to minimize hearing damage caused by the insertion of a cochlear implant electrode: a guinea pig animal model. Giordano P; Hatzopoulos S; Giarbini N; Prosser S; Petruccelli J; Simoni E; Faccioli C; Astolfi L; Martini A Otol Neurotol; 2014 Sep; 35(8):1440-5. PubMed ID: 24853240 [TBL] [Abstract][Full Text] [Related]
34. Continuous topical drug delivery using osmotic pump in animal cochlear implant model: Continuous steroid delivery is effective for hearing preservation. Lee MY; Lee JH; Lee HS; Choi JJ; Jang J; Choi H; Oh SH; Jang JH Acta Otolaryngol; 2015 Aug; 135(8):791-8. PubMed ID: 25813859 [TBL] [Abstract][Full Text] [Related]
35. Development of an electrode for the artificial cochlear sensory epithelium. Tona Y; Inaoka T; Ito J; Kawano S; Nakagawa T Hear Res; 2015 Dec; 330(Pt A):106-12. PubMed ID: 26299844 [TBL] [Abstract][Full Text] [Related]
36. Biopolymer-released dexamethasone prevents tumor necrosis factor alpha-induced loss of auditory hair cells in vitro: implications toward the development of a drug-eluting cochlear implant electrode array. Dinh C; Hoang K; Haake S; Chen S; Angeli S; Nong E; Eshraghi AA; Balkany TJ; Van De Water TR Otol Neurotol; 2008 Oct; 29(7):1012-9. PubMed ID: 18818545 [TBL] [Abstract][Full Text] [Related]
37. Effect of both local and systemically administered dexamethasone on long-term hearing and tissue response in a Guinea pig model of cochlear implantation. Lee J; Ismail H; Lee JH; Kel G; O'Leary J; Hampson A; Eastwood H; O'Leary SJ Audiol Neurootol; 2013; 18(6):392-405. PubMed ID: 24192718 [TBL] [Abstract][Full Text] [Related]
39. Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes. Lyu AR; Kim DH; Lee SH; Shin DS; Shin SA; Park YH PLoS One; 2018; 13(3):e0195230. PubMed ID: 29601595 [TBL] [Abstract][Full Text] [Related]